C1-esterase inhibitor reduces reperfusion injury after lung transplantation

Ann Thorac Surg. 2002 Jan;73(1):233-8; discussion 238-9. doi: 10.1016/s0003-4975(01)03235-0.

Abstract

Background: Activation of the complement system and polymorphonuclear neutrophilic leukocytes plays a major role in mediating reperfusion injury after lung transplantation. We hypothesized that early interference with complement activation would reduce lung reperfusion injury after transplantation.

Methods: Unilateral left lung autotransplantation was performed in 6 sheep. After hilar stripping the left lung was flushed with Euro-Collins solution and preserved for 2 hours in situ at 15 degrees C. After reperfusion the right main bronchus and pulmonary artery were occluded, leaving the animal dependent on the reperfused lung (reperfused group). C1-esterase inhibitor group animals (n = 6) received 200 U/kg body weight of C1-esterase inhibitor as a short infusion, half 10 minutes before, the other half 10 minutes after reperfusion. Controls (n = 6) underwent hilar preparation only. Pulmonary function was assessed by alveolar-arterial oxygen difference and pulmonary vascular resistance. The release of beta-N-acetylglucosaminidase served as indicator of polymorphonuclear neutrophilic leukocyte activation. Extravascular lung water was an indicator for pulmonary edema formation. Biopsy specimens were taken from all groups 3 hours after reperfusion for light and electron microscopy.

Results: In the reperfused group, alveolar-arterial oxygen difference and pulmonary vascular resistance were significantly elevated after reperfusion. All animals developed frank alveolar edema. The biochemical marker beta-N-acetylglucosaminidase showed significant leukocyte activation. In the C1-esterase inhibitor group, alveolar-arterial oxygen difference, pulmonary vascular resistance, and the level of polymorphonuclear neutrophilic leukocyte activation were significantly lower.

Conclusions: Treatment with C1-esterase inhibitor reduces reperfusion injury and improves pulmonary function in this experimental model.

MeSH terms

  • Animals
  • Complement Activation / physiology
  • Complement C1 Inactivator Proteins / therapeutic use*
  • Female
  • Hypertonic Solutions
  • Leukocytes, Mononuclear / physiology
  • Lung / physiology
  • Lung Transplantation* / adverse effects
  • Lung Transplantation* / physiology
  • Models, Animal
  • Organ Preservation Solutions
  • Oxygen / metabolism
  • Reperfusion Injury / prevention & control*
  • Sheep
  • Vascular Resistance

Substances

  • Complement C1 Inactivator Proteins
  • Euro-Collins' solution
  • Hypertonic Solutions
  • Organ Preservation Solutions
  • Oxygen